EUVIMEDEUVIMED entdecken
Crossref

Letrozole‐Based Near‐Infrared Dynamic Imaging Targeting Ductal‐Vascular RhoJ From Pancreatic Intraepithelial Neoplasia to Pancreatic Ductal Adenocarcinoma

Zhi Cao iD, Zhuang Hu iD, Yishu Wang, Fengyun Zhao iD, Jingmin Li iD, Ruihan Li, Weibin Hu iD, Bei Liu, Shaohui Tang, Ping Wang, Fugui Li, Zilin Chen iD und 2 weitere

Advanced Healthcare Materials · 2024-12 · 13 (32)

DOI: 10.1002/adhm.202402913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 27.09.2024. Verfasst von Zhi Cao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Sou…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Letrozole. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Planning Project of Shenzen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) relies heavily on neoangiogenesis for its progression, making early detection crucial. Here, LTZi‐MHI148 (Letrozole inhibitor bonding with MHI‐148 dye), a near‐infrared (NIR) fluorescent agent is developed, to target RhoJ (Ras Homolog Family Member J), a protein expressed in neonatal vasculature, for both imaging and therapy of early PDAC. This agent is synthesized by conjugating Letrozole with MHI‐148, exhibiting excellent NIR characteristics and photostability. In vitro studies showed that LTZi‐MHI148 selectively accumulated within pancreatic cancer cells through Organic Anion Transporting Polypeptide (OATP) transporters and bound to cytoplasmic RhoJ. In vivo, the probe effectively targeted neoangiogenesis and Pancreatic Intraepithelial Neoplasias (PanINs) in various PDAC models, including the orthotopic, ectopic, spontaneous, and tamoxifen‐induced tumors. Notably, LTZi‐MHI148 detected preneoplastic PanIN lesions with Overexpressed RhoJ and active neoangiogenesis in both spontaneous and tamoxifen‐induced PDAC murine models. Longitudinal imaging studies revealed that RhoJ‐targeted neoangiogenesis tracks lesion progression, highlighting LTZi‐MHI148's utility in monitoring disease progression. Furthermore, multiple LTZi‐MHI148 administrations attenuated PanINs to PDAC progression, suggesting its potential as a therapeutic intervention. These findings underscore the translational potential of LTZi‐MHI148 for the early detection and targeted therapy of PDAC, utilizing NIR‐I/II imaging to monitor RhoJ overexpression in precancerous ductal neoplasia associated with neoangiogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsLetrozoleAnimalsHumansMiceCell Line, Tumorrho GTP-Binding ProteinsSpectroscopy, Near-InfraredCarcinoma in SituNeovascularization, PathologicFluorescent Dyes

Stichwörter der Autor:innen

LTZi‐MHI148RhoJdynamic imagingnear‐infrared theranosispancreatic ductal adenocarcinoma

Substanzen

Letrozolerho GTP-Binding ProteinsFluorescent Dyes

Autor:innen und Institutionen

  • Department of Gastroenterology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, 5180…
  • School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, 430071, China.
  • Key Laboratory of Brain, Cognition and Education Sciences, Ministry of Education, China Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou, Guangdong, 510631, China.
  • Cancer Research Institute of Zhongshan City, Zhongshan City People's Hospital, Zhongshan, Guangdong, 528403, China.
  • Internal medicine department, Guangzhou women and children's Medical Center, Guangzhou, Guangdong, 510620, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, 510630, China.

ORCID-Profile: Zhi Cao, Zhuang Hu, Fengyun Zhao, Jingmin Li, Weibin Hu, Zilin Chen, Lisheng Wang, Xiaodong Ma

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Shenzen Municipality

Zitieren

APA

Cao, Z., Hu, Z., Wang, Y., Zhao, F., Li, J., Li, R., Hu, W., Liu, B., Tang, S., Wang, P., Li, F., Chen, Z., Wang, L., & Ma, X. (2024). Letrozole‐Based Near‐Infrared Dynamic Imaging Targeting Ductal‐Vascular RhoJ From Pancreatic Intraepithelial Neoplasia to Pancreatic Ductal Adenocarcinoma. Advanced Healthcare Materials, 13(32). https://doi.org/10.1002/adhm.202402913

Vancouver

Cao Z, Hu Z, Wang Y, Zhao F, Li J, Li R, et al. Letrozole‐Based Near‐Infrared Dynamic Imaging Targeting Ductal‐Vascular RhoJ From Pancreatic Intraepithelial Neoplasia to Pancreatic Ductal Adenocarcinoma. Advanced Healthcare Materials. 2024;13(32). doi:10.1002/adhm.202402913

BibTeX
@article{Cao2024,
  author = {Cao, Zhi and Hu, Zhuang and Wang, Yishu and Zhao, Fengyun and Li, Jingmin and Li, Ruihan and Hu, Weibin and Liu, Bei and Tang, Shaohui and Wang, Ping and Li, Fugui and Chen, Zilin and Wang, Lisheng and Ma, Xiaodong},
  title = {Letrozole‐Based Near‐Infrared Dynamic Imaging Targeting Ductal‐Vascular RhoJ From Pancreatic Intraepithelial Neoplasia to Pancreatic Ductal Adenocarcinoma},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {32},
  doi = {10.1002/adhm.202402913}
}
Kostenlos starten →